Hpv Vaccine and Cervical Cancer: is it Worth Vaccinating?

Health Reviews

April 28, 2010
Posted by Benz

© 2008 Shobha S. Krishnan, M. D. Author Bio

In the last two years, the least campaign for Gardasil, to protect the new HPV vaccine against cervical cancer, the debate about the human papilloma virus in the foreground, bright new light not only on the vaccine itself led, but also on the problems surrounding it. HPV is ubiquitous. Almost 50% of sexually active people will have HPV at some point in their lives. There are about 20 million people with HPV infections in the United States, with 6 2 million new cases each year. The most serious consequence of HPV infections is cervical cancer, but public knowledge of HPV is poor – less than 50% of women had heard about HPV and its relationship to cervical cancer. It is crucial that the public benefits more knowledge about HPV and cervical cancer, especially in the current climate, were at the bottom of the vaccine was clouded by political rhetoric. The information on the relationship between HPV and cervical cancer, how widespread the disease is and who gets it, detection methods, other effects of disease and the role and effectiveness of the vaccine needs to be addressed. The examination of these questions will help the decisions of doctors recommend this vaccine, a whole generation of 11-12 year old girls, children, and perhaps in the future. The relationship between HPV and cervical cancer: There are over 100 HPV types. About 15 of them are causing “high risk”, the cervical cancer. HPV infections are more common in the younger population, with almost 75% of them in the age group 15-25. Most HPV infections are “silent” – people who carry the virus in the know, they have direct and free it, their sexual partners. The good news is that most of these infections, self-limiting, which means that almost 90% of them resolve spontaneously within 24 months, without there being any problem means. are in a minority of people, but infections, either as a result of high-risk sexual behavior (such as multiple partners and unprotected sex) or weakened immunity because of smoking, stress and prolonged use within certain medications such as steroids. These factors can lead to HPV infection and cancer, precancerous lesions of the cervix. About 99% of all cases of cervical cancer are caused by HPV. HPV infection is necessary but not sufficient to lead to cervical cancer. Pap smears and cervical cancer: The Pap test detects early changes in cervical cells by HPV or other effects, which can progress to cervical cancer untreated. organized Fortunately, thanks to a Pap test program in the U.S., the incidence of cervical cancer by 75% in the last 50 years has declined. Therefore, for women to get regular Pap smear, the incidence of cervical cancer is low. Currently in the U.S., approximately 11,000 new cases of cervical cancer develop each year and about 4,000 deaths occur from it. Although one wishes that it expected no cases of cervical cancer, when combined with the number of HPV infections that occur each year, comparing the relationship between HPV infection with cervical cancer is low. According to the American Cancer Society, four out of five women who did not die of cervical cancer through a Pap test within the last five years.



Author: Leslie Carol Botha

Author, publisher, radio talk show host and internationally recognized expert on women's hormone cycles. Social/political activist on Gardasil the HPV vaccine for adolescent girls. Co-author of "Understanding Your Mood, Mind and Hormone Cycle." Honorary advisory board member for the Foundation for the Study of Cycles and member of the Society for Menstrual Cycle Research.